Viimased lisandused - Macular Telangectasia - CNVM OU 60 year old female with vision loss in both eyes for some time. At age 55 she started with injections in the left eye. She then stopped and started several times in both eyes. Her most recent treatment was about 6 months ago and the vision is getting worse.
VA OD 20/160, OS 20/32
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38560 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 37360 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38360 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 39760 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 40560 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 39460 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38860 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38060 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 40960 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 42860 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 40360 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38860 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38660 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38160 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 39560 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 36560 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 37360 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 40760 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38360 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 37160 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 39960 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38860 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 34960 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 35560 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 35960 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 36160 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 38260 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 42160 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 41060 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 39160 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 37060 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
Macular Telangiectasi - Stage V - CNVM OUvaatamisi: 39060 year old female who has been treated with injections for 5 years starting in the left eye. She had no treatment 6 months prior to this visit and her vision has been getting worse. Her vision is 20/100 OD, 20/32 OS. Vision improved with intravitreal Avastin to 20/30 OU.apr 02, 2020
|
|
|
|
60 year old female with vision loss in both eyes for some time. At age 55 she started with injections in the left eye. She then stopped and started several times in both eyes. Her most recent treatment was about 6 months ago and the vision is getting worse.
VA OD 20/160, OS 20/32
